Allen Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Allen Wealth Management's PFE Position: Q2 2026 in Review
Allen Wealth Management reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $172K and leaving 22,464 shares worth $541K. The position accounts for 0.26% of the portfolio, ranked #40.
Allen Wealth Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.86M in Q3 2024. 1,265 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Allen Wealth Management held 22,464 shares of Pfizer worth $541K as of Q2 2026.
- Allen Wealth Management sold 6,576 Pfizer shares in Q2 2026, an estimated $172K.
- Pfizer made up 0.26% of Allen Wealth Management's portfolio in Q2 2026, its #40 holding.
- Allen Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
- Allen Wealth Management's Pfizer position peaked at $2.86M in Q3 2024.
- 1,265 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.